Osiris Therapeutics (OSIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 36,901 | 4,371 | 164 | -2,320 | 8,785 |
| Depreciation Amortization | 873 | 658 | 426 | 211 | 688 |
| Income taxes - deferred | -25,205 | N/A | N/A | N/A | N/A |
| Accounts receivable | 5,113 | 6,699 | 3,295 | -469 | -2,280 |
| Other Working Capital | 6,977 | 6,632 | 3,908 | 2,327 | -5,446 |
| Other Operating Activity | -17,355 | -5,340 | -2,888 | 588 | -6,970 |
| Operating Cash Flow | $7,304 | $13,020 | $4,905 | $337 | $-5,223 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 6,217 | 15,744 | 15,219 | 45 | 7,351 |
| PPE Investments | -242 | -187 | -134 | -100 | -2,008 |
| Investing Cash Flow | $5,975 | $15,557 | $15,085 | $-55 | $5,343 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 7 | N/A | N/A | N/A | 128 |
| Financing Cash Flow | $7 | $0 | $0 | $0 | $128 |
| Beginning Cash Position | 3,081 | 3,081 | 3,081 | 3,081 | 2,833 |
| End Cash Position | 16,367 | 31,658 | 23,071 | 3,363 | 3,081 |
| Net Cash Flow | $13,286 | $28,577 | $19,990 | $282 | $248 |
| Free Cash Flow | |||||
| Operating Cash Flow | 7,304 | 13,020 | 4,905 | 337 | -5,223 |
| Capital Expenditure | -242 | -187 | -134 | -100 | -2,008 |
| Free Cash Flow | 7,062 | 12,833 | 4,771 | 237 | -7,231 |